The MTX2 Knockout Raji Polyclonal Cells are a CRISPR/Cas9-edited polyclonal knockout cell population engineered from the Raji human B lymphocyte cell line, designed to disrupt the MTX2 gene and generate a heterogeneous loss-of-function model. This product provides a versatile tool for investigating the role of the mitochondrial outer membrane protein MTX2 in B-cell biology, without introducing clonal biases inherent to single-cell-derived lines. The polyclonal format preserves the genetic diversity of the edited population, enabling robust functional studies in a context that closely mimics physiological variation. Researchers can employ this model to dissect mitochondrial protein import, apoptosis regulation, and NF-??B signaling dynamics in a well-characterized Burkitt lymphoma background.
Human Burkitt lymphoma Raji cells, which are Epstein-Barr virus (EBV)-positive B lymphocytes, serve as a classic model system for studying B-cell malignancies, immune response mechanisms, and antibody production. Derived from a patient with Burkitt lymphoma, these cells recapitulate key oncogenic signaling pathways and mitochondrial adaptations characteristic of aggressive B-cell cancers. The EBV-positive status further enhances their utility for investigating viral latency and its intersection with cellular signaling networks. This host cell line offers a clinically relevant platform for exploring how MTX2 disruption affects B-cell survival and proliferation, making it suitable for both basic research and translational applications.
MTX2 encodes a mitochondrial outer membrane protein that plays a dual role in mitochondrial protein import and apoptosis modulation. It forms complexes with SAM50, metaxin 1, and components of the TOM and SAM complexes to facilitate translocation of precursor proteins into mitochondria. Additionally, MTX2 interacts with TRAF6, a key adaptor in the NF-??B pathway, and mediates signaling downstream of TNF-?? and IL-1??. Through this interaction, MTX2 regulates NF-??B target gene expression and cytochrome c release, thereby linking mitochondrial import machinery to cell survival decisions. This mechanistic connection positions MTX2 at a critical node between mitochondrial homeostasis and immune signaling.
Disruption of MTX2 in Raji B cells impairs mitochondrial protein import and disrupts NF-??B activation, potentially altering cell viability and apoptotic responses. Given that Raji cells are heavily dependent on NF-??B signaling for proliferation and evasion of apoptosis, this knockout model provides a powerful system to elucidate how mitochondrial outer membrane functions converge with immune signaling networks in B-cell lymphomas. The loss of MTX2 may reveal vulnerabilities in mitochondrial-immune crosstalk that could be targeted in Burkitt lymphoma and other B-cell malignancies. This model thus serves as a valuable resource for identifying novel therapeutic targets and understanding mitochondrial contributions to lymphomagenesis.
Typical research applications include studying mitochondrial protein import mechanisms using import assays and co-immunoprecipitation to assess interactions with SAM50 and TRAF6. NF-??B signaling can be monitored via luciferase reporter assays and Western blotting for pathway components, while apoptosis is evaluated through annexin V staining and flow cytometry. RT-qPCR and immunofluorescence enable quantification of gene expression and protein localization, and cell viability assays support functional screening in B-cell malignancy contexts. For additional information or custom inquiries, please contact Ascent Research.
